Genetics and Epigenetics of Atopic Dermatitis: An Updated Systematic Review
Open accessThe DOI matches its Crossref record; 201 of the 205 references it cites were found in a registry or an index.
Abstract
Background: Atopic dermatitis is a common inflammatory skin disorder that affects up to 15–20% of the population and is characterized by recurrent eczematous lesions with intense itching. As a heterogeneous disease, multiple factors have been suggested to explain the nature of atopic dermatitis (AD), and its high prevalence makes it necessary to periodically compile and update the new information available. In this systematic review, the focus is set at the genetic and epigenetic studies carried out in the last years. Methods: A systematic literature review was conducted in three scientific publication databases (PubMed, Cochrane Library, and Scopus). The search was restricted to publications indexed from July 2016 to December 2019, and keywords related to atopic dermatitis genetics and epigenetics were used. Results: A total of 73 original papers met the inclusion criteria established, including 9 epigenetic studies. A total of 62 genes and 5 intergenic regions were described as associated with AD. Conclusion: Filaggrin (FLG) polymorphisms are confirmed as key genetic determinants for AD development, but also epigenetic regulation and other genes with functions mainly related to the immune system and extracellular matrix, reinforcing the notion of skin homeostasis breakage in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, there are microRNAs that are up- or downregulated in the skin or serum of patients with AD, such as MiR-144, associated with early onset of the disease.”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“Similarly, the most relevant associations of signaling pathways analyzed by the Reactome database were those of the interleukins IL4/IL-13, IL-2 and IL-12.”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“The filaggrin gene (FLG) shows a great diversity of ethnic-dependent genetic mutations and is the most frequently studied gene in AD studies, and certain variations are associated with more severe forms of the disease.”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681 · cited 1×
“This systematic review has been performed using the PRISMA guidelines for Systematic Reviews and Meta-Analysis 2009 checklist and GRADE recommendations [18].”
MethodThe Reactome pathway Knowledgebase
Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,605
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
Norderyd, O. M., Koch, G., Papias, A., Köhler, A. A., Helkimo, A. N., Brahm, C., Lindmark, U., Lindfors, N., Mattsson, A., Rolander, B., et al. (2015) · PubMed · Cited by 3,584
CpG islands and the regulation of transcription
Deaton, A. M., & Bird, A. (2011) · Genes & Development · doi:10.1101/gad.2037511 · Cited by 3,187
Atopic Dermatitis: Global Epidemiology and Risk Factors
Nutten, S. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000370220 · Cited by 3,055
Research works printed but not linked: 1
- Sterne, 2019, RoB 2: A revised Cochrane risk-of-bias tool for randomized trials, BMJ, 366, l48981
Cited by
Langan, S. M., Irvine, A. D., & Weidinger, S. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31286-1 · Cited by 1,852
Molecular Mechanisms of Atopic Dermatitis Pathogenesis
Sroka-Tomaszewska, J., & Trzeciak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084130 · Cited by 577
“Specific sequences enable them to bind to specific mRNAs, resulting in mRNA degradation or translation inhibition [23,35,36].”
BackgroundInfluentialChu, D. K., Schneider, L., Asiniwasis, R. N., Boguniewicz, M., De Benedetto, A., Ellison, K., Frazier, W. T., Greenhawt, M., Huynh, J., Kim, E., et al. (2024) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2023.11.009 · Cited by 380
The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment
Facheris, P., Jeffery, J., Del Duca, E., & Guttman-Yassky, E. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00992-4 · Cited by 237
Genetic and Epigenetic Aspects of Atopic Dermatitis
Nedoszytko, B., Reszka, E., Gutowska‐Owsiak, D., Trzeciak, M., Lange, M., Jarczak, J., Niedoszytko, M., Jabłońska, E., Romantowski, J., Strapagiel, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186484 · Cited by 189
“The fourth group includes interleukin genes produced by keratinocytes exposed to stress, e.g., UV or mechanical trauma (alarmins): IL-25, TSLP, IL-33 [7,8,13,14,17,19].”
BackgroundInfluentialBonamonte, D., Filoni, A., Vestita, M., Romita, P., Foti, C., & Angelini, G. (2019) · BioMed Research International · doi:10.1155/2019/2450605 · Cited by 123
Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis
Kader, H. A., Azeem, M., Jwayed, S. A., Al-Shehhi, A., Tabassum, A., Ayoub, M. A., Hetta, H. F., Waheed, Y., Iratni, R., Aldhaheri, A., et al. (2021) · Cells · doi:10.3390/cells10061392 · Cited by 105
“Genetic Susceptibility: Recent advancements in molecular medicine have facilitated genome-wide association studies and single nucleotide polymorphism studies [36].”
BackgroundEleven loci with new reproducible genetic associations with allergic disease risk
Ferreira, M. A. R., Vonk, J. M., Baurecht, H., Marenholz, I., Tian, C., Hoffman, J., Helmer, Q., Tillander, A., Ullemar, V., Lu, Y., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.03.012 · Cited by 66
Update on the pathogenesis of atopic dermatitis.
Criado, P. R., Miot, H. A., Bueno-Filho, R., Ianhez, M., Criado, R. F. J., & de Castro, C. C. S. (2024) · Anais brasileiros de dermatologia · doi:10.1016/j.abd.2024.06.001 · Cited by 66
Epigenetic alterations in skin homing CD4+CLA+ T cells of atopic dermatitis patients
Acevedo, N., Benfeitas, R., Katayama, S., Bruhn, S., Andersson, A., Wikberg, G., Lundeberg, L., Lindvall, J. M., Greco, D., Kere, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74798-z · Cited by 56
Jaworek, A., Szepietowski, J. C., Hałubiec, P., Wojas‐Pelc, A., & Jaworek, J. M. (2021) · Antioxidants · doi:10.3390/antiox10081179 · Cited by 56
“It is noteworthy that an increase in psychic condition of AD patients (laughing, when viewing a humorous film), resulted in a significant augmentation in MT peak secretion and decrease in blood IgE [90].”
BackgroundInfluentialDębińska, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112506 · Cited by 60
“Dupilumab is a fully human monoclonal antibody that inhibits both IL-4 and IL-13 signaling pathways by blocking their shared IL-4Rα subunit [117,118].”
BackgroundInfluentialZhang, Y., Heinemann, N., Rademacher, F., Darvin, M. E., Raab, C., Keck, C. M., Vollert, H., Fluhr, J. W., Gläser, R., Harder, J., et al. (2022) · Antioxidants · doi:10.3390/antiox11061071 · Cited by 52
“Loss-of-function mutations in filaggrin have been identified as important genetic determinants for AD development [6,7].”
BackgroundA new era of atopic eczema research: Advances and highlights
Hülpüsch, C., Weins, A. B., Traidl‐Hoffmann, C., & Reiger, M. (2021) · Allergy · doi:10.1111/all.15058 · Cited by 45
Pessôa, R., Clissa, P. B., & Sanabani, S. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814322 · Cited by 48
Blicharz, L., Rudnicka, L., Czuwara, J., Waśkiel‐Burnat, A., Goldust, M., Olszewska, M., & Samochocki, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168403 · Cited by 44
“According to the literature, gene polymorphisms resulting in the overexpression of certain types of kallikrein-related proteases were linked to AD [46].”
BackgroundB cells: The many facets of B cells in allergic diseases
Satitsuksanoa, P., Iwasaki, S., Boersma, J., Imam, M. B., Schneider, S. R., Chang, I., van de Veen, W., & Akdiş, M. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.05.011 · Cited by 39
Darlenski, R., Kozyrskyj, A. L., Fluhr, J. W., & Caraballo, L. R. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.10.002 · Cited by 41
Fukushima‐Nomura, A., Kawasaki, H., Yashiro, K., Obata, S., Tanese, K., Ebihara, T., Saeki, H., Etoh, T., Hasegawa, T., Yazaki, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59340-x · Cited by 40
“The high-weighted genes in SKITm2, such as FLG, FLG2 , and LOR , are well-knownasgeneticriskfactorsinAD 7,45 .”
The Proteome of Hand Eczema Assessed by Tape Stripping
Sølberg, J., Quaade, A. S., Drici, L., Sulek, K., Ulrich, N. H., Løvendorf, M. B., Thyssen, J. P., Mann, M., Dyring‐Andersen, B., & Johansen, J. D. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.12.024 · Cited by 33
Atopic Dermatitis: The Fate of the Fat
Pavel, P., Blunder, S., Moosbrugger‐Martinz, V., Elias, P. M., & Dubrac, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042121 · Cited by 38
“Heterogeneity of AD due to genetic polymorphism extends beyond filaggrin (FLG) loss-of-function mutations, since patients with serine peptidase inhibitor Kazal-type 5 (SPINK5) mutations also exhibit a severe AD-like phenotype, as do other patients with inherited disorders [17,18].”
BackgroundGoing, Toll-like receptors in skin inflammation and inflammatory diseases
Kumar, V. (2021) · EXCLI journal · doi:10.17179/excli2020-3114 · Cited by 53
Dębińska, A., & Sozańska, B. (2023) · Nutrients · doi:10.3390/nu15051070 · Cited by 33
Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis
Rusiñol, L., & Puig, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021042 · Cited by 32
“Epigenetic changes in patients with AD and psoriasis involve genes that regulate immune response and inflammatory processes and those that code for structural proteins of the epidermis [56,146–149].”
BackgroundMethodInfluentialCLA+ memory T cells in atopic dermatitis: CLA+ T cells and atopic dermatitis
Nicolàs, L. S. S., Czarnowicki, T., Akdis, M., Pujol, R. M., Lozano‐Ojalvo, D., Leung, D. Y. M., Guttman‐Yassky, E., & Santamaria‐Babí, L. F. (2024) · Allergy · doi:10.1111/all.15816 · Cited by 25
“76 Acevedo et al. showed that in AD patients, CD4 + CLA + memory T cells are characterized by dysregulated epigenetic signatures affecting key cytokine signaling pathways, with a reduced DNA methylation in the upstream region of IL13 gene that correlates with increased IL13 mRNA expression in these…”
BackgroundStaphylococcus Infection: Relapsing Atopic Dermatitis and Microbial Restoration
Hulme, J. (2023) · Antibiotics · doi:10.3390/antibiotics12020222 · Cited by 22
“Additional epigenetic studies have shown that high exposure to smoke can lead to hypomethylation of the thymic stromal lymphopoietin (TSLP) 5′CpG island in pregnant women and is positively correlated with AD [30].”
Olejnik, A., Gornowicz‐Porowska, J., Jenerowicz, D., Polańska, A., Dobrzyńska, M., Przysławski, J., Sansone, A., & Ferreri, C. (2023) · Nutrients · doi:10.3390/nu15173857 · Cited by 26
“The last is represented by genes that regulate the vitamin D pathways (CYP27A1, CYP2R1, VDR) [40,41].”
BackgroundIbba, L., Falcidia, C., Giulio, S. D., Bianco, M., Valenti, M., Facheris, P., Narcisi, A., Costanzo, A., & Gargiulo, L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092953 · Cited by 25
“Loss-of-function mutations in FLG are strongly associated with AD, especially in Europe and Asia, and increase susceptibility to asthma and peanut allergies [4,5].”
Wen, H., Wang, S., Chen, P., & Guo, Y. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210708 · Cited by 23
Relationship Between Atopic Dermatitis and Food Allergy in Children
Mehta, Y., & Fulmali, D. G. (2022) · Cureus · doi:10.7759/cureus.33160 · Cited by 25
“Atopic illnesses run in families for about 70% of AD patients [16].”
BackgroundPasanen, A., Sliz, E., Huilaja, L., FinnGen, Reimann, E., Mägi, R., Laisk, T., Tasanen, K., & Kettunen, J. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.02.036 · Cited by 23
Dvornyk, V., Ponomarenko, I., Belyaeva, T. M., Reshetnikov, E., & Churnosov, M. I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261026 · Cited by 22
“Familial and twin studies have demonstrated that AD is a highly heritable disease: genetic factors account for nearly 90% of the disease susceptibility variance [12,13].”
BackgroundKhatib, C. M., Klein‐Petersen, A. W., Rønnstad, A. T. M., Egeberg, A., Christensen, M. O., Silverberg, J. I., Thomsen, S. F., Irvine, A. D., & Thyssen, J. P. (2024) · Experimental Dermatology · doi:10.1111/exd.15130 · Cited by 24
Elhaji, Y. A., Sasseville, D., Pratt, M. D., Asai, Y., Matheson, K. J., McLean, W. H. I., & Hull, P. R. (2019) · Contact Dermatitis · doi:10.1111/cod.13268 · Cited by 17
Shehwana, H., Ijaz, S., Fatima, A., Walton, S. F., Sheikh, Z. I., Haider, W., & Naz, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.778840 · Cited by 17
Preclinical Models of Atopic Dermatitis Suitable for Mechanistic and Therapeutic Investigations
Maskey, A., Mo, X., & Li, X.-M. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s467327 · Cited by 17
“15 17 The most important risk gene identified in eczema is filaggrin (FLG), a major component of the stratum corneum (SC).”
BackgroundSobiak, B., & Leśniak, W. (2020) · Cells · doi:10.3390/cells9122628 · Cited by 13
“Even though the involvement of epigenetic components has been identified in many of the above phenomena [35,36], the regulation of epidermal differentiation by epigenetic factors, including histone modifications, remains relatively unexplored [13].”
BackgroundBreak on Through: The Role of Innate Immunity and Barrier Defence in Atopic Dermatitis and Psoriasis
Hawerkamp, H. C., Fahy, C. M. R., Fallon, P. G., & Schwartz, C. (2022) · Skin Health and Disease · doi:10.1002/ski2.99 · Cited by 16
“Detailed reviews on the genetics of AD and psoriasis were also recently published by Martin et al.(65) and Ogawa and Okada,(66) respectively.”
BackgroundAdvancements in Allergen Immunotherapy for the Treatment of Atopic Dermatitis
Guo, B.-C., Wu, K., Chen, C., Lin, W.-Y., Chang, Y., Lin, M.-J., & Wu, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021316 · Cited by 15
“In addition to the FLG gene, more than sixty other genes are implicated in AD [32].”
BackgroundHartmane, I. (2024) · Plastic and Aesthetic Nursing · doi:10.1097/psn.0000000000000564 · Cited by 14
“Martin et al. (2020) and Brown et al. (2020) argued that mastocytes (i.e., white blood cells that fight antigens [i.e., toxins that induce an immune response in the body]) play a key role in the release of inflammatory mediators.”
Livshits, G., & Kalinkovich, A. (2024) · Cells · doi:10.3390/cells13221899 · Cited by 16
“Major advances are related to a better understanding of genetic and epigenetic regulation [39,40,58], the role of innate immunity [59,60], the involvement of T-cell subsets and cytokines [61–63], the role of skin and gut dysbiosis [49,50,64], and mechanisms of epithelial barrier disruption in the…”
Toward Precision Medicine in Atopic Dermatitis Using Molecular-Based Approaches
Carrascosa, J. M., Aterido, A., Li, T., Guillén, Y., Martinez, S., Marsal, S., & Julià, A. (2023) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2023.08.003 · Cited by 16
Bratu, D., Boda, D., & Căruntu, C. (2023) · Healthcare · doi:10.3390/healthcare11020152 · Cited by 14
Hartmann, D., Retamal, C., & Valenzuela, F. (2025) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abd.2025.501135 · Cited by 14
Thomas, B., Tan, X. L., van Duijvenboden, S., Hogan, S., Hughes, A., Tawfik, S. S., Dhoat, S., Atkar, R., Robinson, E. J., Rahman, S. R., et al. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad036 · Cited by 11
Genomic, Epigenomic, Transcriptomic, Proteomic and Metabolomic Approaches in Atopic Dermatitis
Bratu, D., Boda, D., & Căruntu, C. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45060331 · Cited by 13
Almutawa, Y. M., AlGhareeb, M., Bhattarai, E., & Aljalahma, J. (2024) · Cureus · doi:10.7759/cureus.63376 · Cited by 25
“The notion that skin homeostasis is disrupted in AD is reinforced by the identification of Filaggrin polymorphisms as key genetic factors in AD development, along with epigenetic regulation and other genes mainly involved in the immune system and extracellular matrix [8].”
BackgroundDębińska, A., Danielewicz, H., & Sozańska, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164865 · Cited by 9
“Among the 34 specific genomic regions identified as associated with atopic eczema susceptibility, the FLG loss-of-function mutations remain the strongest and most replicated risk factors reported to date [18,19,21,22,56].”
BackgroundThe Acari Hypothesis, III: Atopic Dermatitis
Retzinger, A. C., & Retzinger, G. S. (2022) · Pathogens · doi:10.3390/pathogens11101083 · Cited by 8
“As loss-of-function mutations in proteins that maintain epidermal barrier function are a significant risk factor for AD [29,30], the latter hypothesis is favored.”
BackgroundArtusa, S., Mazzuca, G., PIACENTINI, G. L., Castagnoli, R., Marseglia, G. L., Pietrobelli, A., & Pecoraro, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094778 · Cited by 13
“This protein is crucial in the differentiation of the epidermidis and in creating the skin barrier [12,13].”
BackgroundInfluentialLuo, H., & Wen, F. (2024) · Allergy · doi:10.1111/all.16449 · Cited by 7
Mandal, S., Ghosh, S., Das, A. D., Biswas, B., Palanisamy, C., Guha, N., Maiti, S., Dutta, S., Singh, N., Koley, M., et al. (2023) · Homeopathy · doi:10.1055/s-0042-1760339 · Cited by 7
Unlocking the molecular pathway of atopic dermatitis: journey so far and roads ahead
Kumar, S., Sharma, R. R., Komal, K., Kumar, D., Ghosh, R., & Kumar, M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01900-0 · Cited by 7
“The second and third groups comprise genes linked to the impairment of innate or adaptive immune response mechanisms, respectively (Martin et al. 2020).”
Epidermal Barrier Dysfunction in Atopic Dermatitis
Gomes, T. F., Calado, R., & Gonçalo, M. (2021) · Journal of the Portuguese Society of Dermatology and Venereology · doi:10.29021/spdv.79.3.1405 · Cited by 6
Perälä, M., Kaustio, M., Salava, A., Jakkula, E., Pelkonen, A. S., Saarela, J., Remitz, A., & Mäkelä, M. J. (2023) · JID Innovations · doi:10.1016/j.xjidi.2023.100203 · Cited by 5
“In addition to FLG variants, associations with higher risk or severity of AD have been found for variants in many other genes affecting epidermal barrier integrity or the immune response (Liang et al., 2016; Martin et al., 2020).”
BackgroundDessì, A., Maria, C. D., Pintus, R., Fanos, V., & Bosco, A. (2023) · Current Pediatric Reviews · doi:10.2174/1573396320666230411093122 · Cited by 6
Antisense molecules: A promising new therapy for atopic dermatitis
Xue, J., & Yao, Z. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.008 · Cited by 5
“…miR-223 expression in umbilical cord blood, reduces methylation levels at the TSLP 5 ′ CpG island, and alters DNA methylation patterns at the forkhead box protein 3 locus, leading to reduced Treg cell counts and heightened susceptibility to AD within the first three years of life 99,111,112 .”
Zhao, W., Ye, P., Yang, H., Yang, Y., Zhu, S., Cheung, H. J., Yang, B., Liang, Y., & Li, C. (2025) · International Journal of Dermatology · doi:10.1111/ijd.70085 · Cited by 4
“This results in newborns having lower Treg cell counts at birth, which increases the likelihood of developing AD or food allergies in early childhood [25, 34].”
Carrascosa, J. M., Aterido, A., Li, T., Guillén, Y., Martinez, S., Marsal, S., & Julià, A. (2023) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2023.10.032 · Cited by 4
Molecular-genetic determinants of atopic dermatitis (data from genome-wide studies)
Belyaeva, T. M., Ponomarenko, I., & Churnosov, M. I. (2020) · Russian Journal of Clinical Dermatology and Venereology · doi:10.17116/klinderma202019051615 · Cited by 3
Wang, D., Wu, X., Yan, S., Zhou, T., Huang, Y.-J., Li, J., & Luo, X. (2022) · PubMed · doi:10.7499/j.issn.1008-8830.2202098 · Cited by 4
Fernández, A. T., Vicente, A., Martin‐Santiago, A., Laguna, R. D. L., Armario-Hita, J. C., Moro, R., Díaz‐Cerezo, S., Lizán, L., & Núñez, M. (2024) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2024.06.011 · Cited by 6
Danielidi, A., Lygeros, S., Anastogianni, A., Danielidis, G., Georgiou, S., Stathopoulos, C., & Grafanaki, K. (2025) · Allergies · doi:10.3390/allergies5020009 · Cited by 6
Fornal, R., Książkiewicz, A., Fornal, A., & Zarzycka, D. (2022) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2022-0033 · Cited by 4
Modern concepts of the pathogenesis of atopic dermatitis
Gorskii, V., & Blyumina, V. (2022) · Immunopathology Allergology Infectology · doi:10.14427/jipai.2022.3.70 · Cited by 3
Zhang, Y., Pan, H., Rai, S., Liu, R., & Liu, B. (2023) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1155/2023/9067797 · Cited by 5
“Activated proteins form dimers and translocate into the nucleus to modulate the expression of genes and fnally regulate type-2 diferentiation, T-cell activation, innate immunity, and epidermal diferentiation complexes [6, 23].”
Circulating CLA+ Memory T Cells in Skin Diseases: A Translational Perspective
Czarnowicki, T., Tordjman, L., García‐Jiménez, I., & Santamaria‐Babí, L. F. (2025) · JID Innovations · doi:10.1016/j.xjidi.2025.100403 · Cited by 5
You, J., Reilly, M., Eljalby, M., Bareja, R., Yusupova, M., Vyas, N. S., Bang, J., Ding, W., Desman, G. T., Miller, L. S., et al. (2023) · Experimental Dermatology · doi:10.1111/exd.14811 · Cited by 2
Indoor particulate matter induces epigenetic changes in companion atopic dogs
Kim, J., Kim, Y., Song, Y., Kim, T. J., Lee, S., & Kim, H. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115544 · Cited by 7
Bergasa, N. V. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110925 · Cited by 1
Antonova, S. B., Уфимцева, М. А., Makeev, O. G., Desyatova, M. A., Mylnikova, E., Nikolaeva, K. I., & Efimova, M. S. (2024) · Vestnik dermatologii i venerologii · doi:10.25208/vdv1403 · Cited by 1
A lethal disease of the European bison – posthitis is conditionally determined by its genomics
Kunvar, S., Czarnomska, S. D., Pertoldi, C., Strønen, A. V., Ruczyńska, I., & Tokarska, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-88702-0 · Cited by 1
Epigenetic Modification in Preclinical and Clinical Dermatological Itch Conditions
Fujishiro, A., Vecchio, S. L., Giordano, R., Yosipovitch, G., & Arendt‐Nielsen, L. (2026) · European Journal of Pain · doi:10.1002/ejp.70214 · Cited by 1
“…et al. 2023; Chen et al. 2023; Domingo et al. 2020; Hołdrowicz and Woźniacka 2024; Khosrojerdi et al. 2024; Livshits and Kalinkovich 2024; Martin et al. 2020; Mu and Zhang 2020; Nedoszytko et al. 2020; Özdemіr and Öksüz 2024; Savva et al. 2024; Schmidt and de Guzman Strong 2021; da Silva…”
Husain, I., Patel, K., Holden, C., Jervis, L., Barnard, K., Youssef, E., Felton, J., Bremner, S. A., Brown, S. M., & Mukhopadhyay, S. (2026) · Pediatric Allergy and Immunology · doi:10.1111/pai.70326 · Cited by 1
“91,92 With respect to additional skin- barrier-associated genes, Pontikas et al. report consistent associations between AD and FLG-2 , 91 which was found in only one included paper for our review and thus could not be meta-analyzed, CLDN-1 as a result of a whole-exome sequencing (WES) study, 93 and…”
Makeev, O. G., Antonova, S. B., Уфимцева, М. А., Efimova, M. S., Mylnikova, E., Korotkov, A. V., Shuman, E. A., Sichkar, D. A., & Desyatova, M. A. (2022) · Kazan medical journal · doi:10.17816/kmj2022-100 · Cited by 1
Microbioma cutâneo e dermatite atópica
Abreu, D. B., Silva, D., Moreira, A. M., Lopes, C., & Unidade de Imunoalergologia, U. L. D. S. (2022) · Revista Portuguesa de Imunoalergologia · doi:10.32932/rpia.2022.09.086 · Cited by 9
Integrative Approaches to Sleep Management in Skin Disease: Systematic Review
Kulkarni, V., Mojica, I., Gamsarian, V., Tahjian, M., Liu, D. S., Grewal, T., Liu, Y., Sivesind, T. E., & Lio, P. (2023) · JMIR Dermatology · doi:10.2196/48713 · Cited by 1
Epigenetic Studies of Atopic Dermatitis
Sobolev, V. V., Петровна, Б. Е., & Свитич, О. А. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.94092 · Cited by 1
Okui, T., & Nakashima, N. (2022) · Allergies · doi:10.3390/allergies2020004 · Cited by 1
“These are also risk factors for atopic dermatitis [37,38].”
BackgroundPasanen, A., Sliz, E., Huilaja, L., FinnGen, Reimann, E., Mägi, R., Laisk, T., Tasanen, K., & Kettunen, J. (2022) · medRxiv · doi:10.1101/2022.12.08.22283257 · Cited by 1
The Use of Dupilumab in Atopic Dermatitis During Coronavirus Disease-19 Era – A Review
Kosasih, L. P. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.5359
“For instance, some individuals may have filaggrin mutation; filaggrin is a gene that encodes essential proteins in building the epithelial barrier and ceramide, a lipid substance that plays an important role in retaining water permeability barrier function [22], [23] The lack of these two major materials leads to exce…”
BackgroundLima, L. D. P. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-28092021-090259 · Cited by 1
Title: A new era of atopic eczema research: Advances and highlightsPreprint
Hülpüsch, C., Weins, A. B., Traidl‐Hoffmann, C., & Reiger, M. (2021) · doi:10.22541/au.162024887.79841945/v1
“[2, 83] Multiple mutations in the innate immune system pathways (e.g. ADAM33, MIF, MMP9, ORM2, RETN, and TLR2)[50], as well as a lack of antimicrobial peptides (AMPs) were reported in the context of AE.”
BackgroundClinical Evidence: Internal Factors
Chan, L. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-84744-5.00018-8
Sarkis, A.-S., & Stéphan, F. (2022) · EMC - Dermatología · doi:10.1016/s1761-2896(22)46752-5 · Cited by 2
Soriano, V. X., Eigenmann, P., & Peters, R. L. (2023) · Pediatric Allergy and Immunology · doi:10.1111/pai.13906
Diet therapy as support for the treatment of atopic dermatitis
Chrzanowska, E., Winiarska‐Mieczan, A., & Jachimowicz-Rogowska, K. (2023) · Aesthetic Cosmetology and Medicine · doi:10.52336/acm.2023.010 · Cited by 1
Genetic determinants of atopic dermatitis
Гребенникова, И. П., Morrison, A. V., Te, L., & Yeremina, M. G. (2024) · Russian Journal of Skin and Venereal Diseases · doi:10.17816/dv607439
Fernández, A. T., Vicente, A., Martin‐Santiago, A., Laguna, R. D. L., Armario-Hita, J. C., Moro, R., Díaz‐Cerezo, S., Lizán, L., & Núñez, M. (2025) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2025.01.005
Biomarkers in Atopic Dermatitis
Parraga, S. P., Cook, M. K., & Feldman, S. R. (2025) · Springer eBooks · doi:10.1007/978-3-031-66513-4_4
Hartmann, D., Retamal, C., & Valenzuela, F. (2025) · Anais Brasileiros de Dermatologia (Versão em Português) · doi:10.1016/j.abdp.2025.501135
Atopic dermatitis: pathogenetic mechanisms and role of biomarkers in diagnosis
Borukaeva, I. K., Temirzhanova, F. K., Юрьевич, Ш. К., Abazova, Z. K., & Getigezheva, A. Z. (2025) · Kazan medical journal · doi:10.17816/kmj680075 · Cited by 1
Dębińska, A., Danielewicz, H., Drabik-Chamerska, A., & Sozańska, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010346 · Cited by 1
“Although individual associations between genetic variants and atopic diseases [29–34], as well as between ETS exposure and allergic outcomes [21,24,35], are well established, research exploring their combined effects, particularly in relation to the asthma–eczema comorbidity, remains limited.”
Receptor de muerte programada 1 (PD-1): un blanco terapéutico novedoso en dermatitis atópica
Carvajal, M., & Lopera, M. M. V. (2026) · Piel · doi:10.1016/j.piel.2025.09.011
Yaralı, O., & Güler, T. (2026) · New Trends in Medicine Sciences · doi:10.56766/ntms.1744180
КОМОРБИДНОСТЬ АТОПИЧЕСКОГО ДЕРМАТИТА И ЗАБОЛЕВАНИЙ ЖЕЛУДОЧНО-КИШЕЧНОГО ТРАКТА
Чубачук, И. Ю., & Попова, Н. И. (2026) · Международный студенческий научный вестник (International Student Scientific Herald) · doi:10.17513/msnv.22142
Unresolved questions and challenges in immunogenetics
Kumar, R., Mishra, P. S., Sheikh, A., RAHMAN, S., Mishra, R., & Patel, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33590-7.00013-7
Lee, J. Y., Loo, E. X. L., Chong, S. S., Ban, K. H.-K., & Lee, C. G. L. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01533-1
“…but most were limited to a single biomolecular domain—such as metabolomics, skin microbiome or microRNA (Yu et al. 2020; Niemeyer‐ van der et al 2018; Martin et al. 2020; Upadhyay et al. 2023; Zhang et al. 2023; Vaughn et al. 2019), or restricted to specific sample sites, such as serum and plasma…”
Atopic Dermatitis in the Era of Exposome and Artificial Intelligence
Manti, S., Pomi, F. L., Gammeri, L., Borgia, F., Murdaca, G., & Gangemi, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209209 · Cited by 1
“…levels) may identify potential biomarkers not only of disease severity, but also exposure-related responses, propensity to relapse, or imminent transition to the acute phase [32–34 ,42 ,43, Ultimately, these potential applications converge toward the broader goal of treatment personalization.”
Metadata
- Authors
- Martin, M. J., Estravís, M., García-Sánchez, A., Dávila, I., Isidoro-García, M., & Sanz, C.
- Affiliations
- Instituto de Investigación Biomédica de Salamanca (ES)
- Universidad de Salamanca (ES)
- Institute for Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2020-04-18
- Volume
- 11
- Issue
- 4
- Pages
- 442
- ISSN
- 2073-4425 (ISSN-L)
- PMC
- PMC7231115
- OpenAlex
- W3016907998
- Semantic Scholar
- 7f4749157d9d39bf8b295abbec5b7d742a525d22
- Cited by
- 99
- References
- 205
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 14 · 2023: 23 · 2022: 16 · 2021: 12 · 2020: 8
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Genes (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Hispana (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Gredos (University of Salamanca) (submittedVersion, cc-by-nc-nd)
- Funders
- Instituto de Salud Carlos III (PI17/00818)
- Network for Cooperative Research in Health - RETICS ARADyAL (RD16/0006/0019)
- Junta de Castilla y León Health Council (GRS1596)
- Junta de Castilla y León Education Council (CAS086P17)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
- Keywords
- atopic dermatitis, genetics, epigenetics, genetic polymorphism, gene-gene interaction, intergenic regions, immune system genes, extracellular matrix genes, skin homeostasis
- MeSH terms
- Filaggrin Proteins, Dermatitis, Atopic, Humans, S100 Proteins, Polymorphism, Genetic, Skin, Genetic Predisposition to Disease, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.